The University of Chicago Header Logo

Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinoma.

Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinoma. Clin Genitourin Cancer. 2009 Jan; 7(1):39-42.

View in: PubMed